Table 5. Genotypes in drug susceptibility profiles of the GenoType MTBDRplus and MDRsl Assays.
| Drug Resistance Patterns and Results of the MDRplus and MDRsl | Number with resistance | Percentage (%) |
|---|---|---|
| Resistance to any drug | 14 | 40.0 |
| Resistance to more than one drug | 2 | 5.7 |
| MDR-TB | 4 | 11.4 |
| Monoresistance to RFP | 2 | 5.7 |
| Monoresistance to INH | 6 | 17.1 |
| Monoresistance to FLQ | 0 | 0 |
| Monoresistance to KAN | 0 | 0 |
| Monoresistance to EMB | 0 | 0 |
| Resistance to REP + INH | 3 | 8.6 |
| Resistance to REP + EMB | 1 | 2.9 |
| Resistance to REP + INH + FLQ | 1 | 2.9 |
| Resistance to INH + FLQ + EMB | 1 | 2.9 |
Notes: MDR-TB-multi-drug resistant tuberculosis; RFP-rifampicin; INH-isoniazid; FLQ-fluoroquinolones; KAN-kanamycin; EMB-ethambutol.